Muhid Bin Shahid, PhDSenior Process Engineer, Chemical Development at AstraZenecaSpeaker
Profile
Muhid joined the Chemical Development department in Pharmaceutical Technology & Development at AstraZeneca in 2021 after completing PhD studies at University of Strathclyde. Since 2021, Muhid significantly contributed to oligonucleotide process development, with a focus on downstream processing, and have supported clinical drug substance manufactures for late-stage oligonucleotide projects.
Agenda Sessions
Streamlining Oligonucleotide Manufacture: Improving Efficiency and Sustainability via Implementation of Single Chromatography
, 15:00View Session